08/11/2023 6:32 p.m., updated 08/11/2023 6:32 p.m
Ozempic is a medication used to control type 2 diabetes. The drug gained popularity due to its weightloss effects and its offlabel use became a global trend.
The family of 56yearold Trisha Webster says the drugs led to her death. While taking the drug, she suffered from diarrhea and vomiting for months side effects predicted in the package leaflet and eventually developed a gastrointestinal illness.
According to a report by television show 60 Minutes, the woman began taking the drug with the intention of slimming down for her daughter’s wedding. She took Ozempic for three months and when the drug became harder to find, she switched to Saxenda, which has a similar effect.
Side effects of use
{{#values}}{{/values}}
Trisha lost 16kg and continued taking the medication despite increasing side effects. In February this year, she fainted and her mouth began to foam. Her husband tried to perform emergency maneuvers, but she died. The autopsy revealed that she suffered from an acute gastrointestinal illness that led to intestinal failure.
Intestinal failure is a very serious condition characterized by the inability of the intestines to adequately absorb nutrients and fluids, compromising health.
For the family, Ozempic was the cause of the woman’s death. Novo Nordisk, the drug’s manufacturer, told 60 Minutes that it was monitoring the case.
The Food and Drug Administration (FDA), the United States’ health watchdog, is monitoring about 50 deaths that have occurred among Ozempic users in the United States, but it has not been able to confirm the link in any of them.
What is Ozempic?
1/4The pens are indicated for the treatment of diabetes. ▲ They work by mimicking hormones that regulate blood sugar and also reduce appetite. ▲ The weight loss effect led to the drug being used “off label”. However, this use is not supported by the manufacturer. ▲ 1234
Follow the Health Editor on Instagram and stay up to date on everything on the topic!
Have you read all the health warnings and reports today? Click here.